ReviewThe Journal of allergy and clinical immunology2020

Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations.

Hans-Hartmut Peter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.